Abstract
Natural cell-mediated cytotoxicity against NK-resistant target tumor cells was found in the peripheral blood of tumor-bearing patients approximately 1 mo after combined chemotherapy. The recognition specificity of these effector cells was broad and had no restriction. From the experiments of negative selection with mAbs and complements, these newly developed killer cells after chemotherapy were thought to be LAK-like cells. Contribution of these LAK-like cells to the mechanism of action of anticancer drugs remains to be clarified.
Full Text
The Full Text of this article is available as a PDF (345.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ballas Z. K. Lymphokine-activated killer (LAK) cells. I. Differential recovery of LAK, natural killer cells, and cytotoxic T lymphocytes after a sublethal dose of cyclophosphamide. J Immunol. 1986 Oct 1;137(7):2380–2384. [PubMed] [Google Scholar]
- Berd D., Mastrangelo M. J., Engstrom P. F., Paul A., Maguire H. Augmentation of the human immune response by cyclophosphamide. Cancer Res. 1982 Nov;42(11):4862–4866. [PubMed] [Google Scholar]
- Gambacorti-Passerini C., Rivoltini L., Supino R., Rodolfo M., Radrizzani M., Fossati G., Parmiani G. Susceptibility of chemoresistant murine and human tumor cells to lysis by interleukin 2-activated lymphocytes. Cancer Res. 1988 May 1;48(9):2372–2376. [PubMed] [Google Scholar]
- Hurme M., Sihvola M. Natural killer (NK) cell activity during lymphatic regeneration: early appearance of Thy-1+ NK cells and highly interleukin 2-(IL 2) receptive, Thy-1- cells. J Immunol. 1983 Aug;131(2):658–661. [PubMed] [Google Scholar]
- Ishii Y., Fujimoto J., Koshiba H., Kikuchi K. Isolation and partial characterization of a 72,000-dalton glycoprotein (Tgp72) on human thymus and T cells: possible relationship to mouse Ly-1 antigens. J Immunol. 1981 Jun;126(6):2171–2176. [PubMed] [Google Scholar]
- Kiyohara T., Dennis J. W., Boegman R. J., Roder J. C. An exoglycosidase-sensitive triggering site on NK cells which is coupled to transmethylation of membrane phospholipids. J Immunol. 1985 Jul;135(1):659–664. [PubMed] [Google Scholar]
- Mantovani A., Luini W., Peri G., Vecchi A., Spreafico F. Effect of chemotherapeutic agents on natural cell-mediated cytotoxicity in mice. J Natl Cancer Inst. 1978 Nov;61(5):1255–1261. doi: 10.1093/jnci/61.5.1255. [DOI] [PubMed] [Google Scholar]
- Minato N., Hattori M., Sudo T., Kano S., Miura Y., Suda J., Suda T. Differentiation in vitro of T3+ large granular lymphocytes with characteristic cytotoxic activity from an isolated hematopoietic progenitor colony. J Exp Med. 1988 Mar 1;167(3):762–776. doi: 10.1084/jem.167.3.762. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nitta K., Tanaka T. [Enhancement of immune response by an antitumor agent, cyclophosphamide]. Gan To Kagaku Ryoho. 1986 Mar;13(3 Pt 2):706–713. [PubMed] [Google Scholar]
- Ortaldo J. R., Mason A., Overton R. Lymphokine-activated killer cells. Analysis of progenitors and effectors. J Exp Med. 1986 Oct 1;164(4):1193–1205. doi: 10.1084/jem.164.4.1193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pizzocaro G., Piva L., Salvioni R., Zanoni F., Milani A. Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer. Cancer. 1985 Nov 15;56(10):2411–2415. doi: 10.1002/1097-0142(19851115)56:10<2411::aid-cncr2820561012>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
- Sihvola M., Hurme M. Defective repertoire of proliferative T cells during lymphatic regeneration. Immunology. 1984 Feb;51(2):313–318. [PMC free article] [PubMed] [Google Scholar]
- Sihvola M. Lymphokine-activated killer cells in mouse bone marrow chimaeras. The relationship to natural killer cells and to alloreactive cytotoxic T cells. Scand J Immunol. 1985 Nov;22(5):479–488. doi: 10.1111/j.1365-3083.1985.tb01906.x. [DOI] [PubMed] [Google Scholar]
- Sternberg C. N., Yagoda A., Scher H. I., Watson R. C., Ahmed T., Weiselberg L. R., Geller N., Hollander P. S., Herr H. W., Sogani P. C. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol. 1985 Mar;133(3):403–407. doi: 10.1016/s0022-5347(17)48996-8. [DOI] [PubMed] [Google Scholar]
- Suzuki R., Handa K., Itoh K., Kumagai K. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells. J Immunol. 1983 Feb;130(2):981–987. [PubMed] [Google Scholar]